Research graph
References from Scaling-up tuberculosis preventive therapy to HIV-negative contacts of bacteriologically confirmed TB cases aged 5 years and above – Lessons from a tuberculosis preventive therapy surge activity in Zambia. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021
10.1186/s40249-024-01227-y · 2024 · External reference
Unresolved reference
External reference
Tuberculosis preventive treatment in high TB-burden settings: A state-of-the-art review
10.1007/s40265-024-02131-3 · 2025 · External reference
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies
10.1016/s2213-2600(24)00083-3 · 2024 · External reference
A controlled trial of community-wide isoniazid prophylaxis in Alaska
1967 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Systematic review of the exploration, preparation, implementation, sustainment (EPIS) framework
10.1186/s13012-018-0842-6 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
10.1183/13993003.00655-2019 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Reasons for poor uptake of TB preventive therapy in South Africa
10.5588/pha.22.0030 · 2022 · External reference
Exploring providers’ perspectives of a community based TB approach in Southern Ethiopia: Implication for community based approaches
10.1186/s12913-015-1149-9 · 2015 · External reference
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis
10.1016/s1473-3099(16)30216-x · 2016 · External reference
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: A cluster-randomised trial
10.1016/s2214-109x(23)00430-8 · 2023 · External reference
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
10.15585/mmwr.rr6901a1 · 2020 · External reference
The global burden of tuberculosis mortality in children: a mathematical modelling study
2017 · External reference
Unresolved reference
External reference
The Prevalence and clinical manifestations of post-tuberculosis lung disease in immunocompetent HIV-negative individuals: A scoping review
2025 · External reference
Post-tuberculosis lung disease: Towards prevention, diagnosis, and care
10.1016/s2213-2600(24)00429-6 · 2025 · External reference
Patient outcomes associated with post-tuberculosis lung damage in Malawi: A prospective cohort study
10.1136/thoraxjnl-2019-213808 · 2020 · External reference
Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru
10.1186/s12889-020-10098-5 · 2021 · External reference
Programmatic management of tuberculosis preventive therapy: past, present, future
10.1016/j.ijid.2023.02.016 · 2023 · External reference
Perceived stigma related to TB preventive therapy
10.5588/ijtld.22.0570 · 2023 · External reference
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: A qualitative study of adolescents, caretakers and health workers
10.1186/s12981-024-00643-2 · 2024 · External reference
The impacts of donor transitions on health systems in middle-income countries: A scoping review
10.1093/heapol/czac063 · 2022 · External reference
The impact of loss of PEPFAR support on HIV services at health facilities in low-burden districts in Uganda
10.1186/s12913-021-06316-4 · 2021 · External reference
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
10.5588/ijtldopen.23.0283 · 2024 · External reference
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
10.5588/ijtldopen.23.0283 · 2024 · External reference
Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: A systematic review
10.1186/s12879-025-10832-7 · 2025 · External reference
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: An individual patient data network meta-analysis
10.1016/s2213-2600(23)00096-6 · 2023 · External reference
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: A systematic review with network meta-analyses
10.1186/s12879-017-2377-x · 2017 · External reference
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
10.1016/s2213-2600(23)00096-6 · 2023 · External reference
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
10.1371/journal.pgph.0003347 · 2024 · External reference
Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda [Internet]
2022 · External reference
The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling
2016 · External reference
More is needed to end TB: Commentary on the United Nations High-Level Meeting on TB
10.5588/ijtldopen.23.0576 · 2024 · External reference
Tuberculosis preventive treatment in high TB-burden settings: A state-of-the-art review
10.1007/s40265-024-02131-3 · ExternalCitation · doi-reference
Programmatic management of tuberculosis preventive therapy: past, present, future
10.1016/j.ijid.2023.02.016 · ExternalCitation · doi-reference
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis
10.1016/s1473-3099(16)30216-x · ExternalCitation · doi-reference
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis
10.1016/s2213-2600(23)00096-6 · ExternalCitation · doi-reference
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies
10.1016/s2213-2600(24)00083-3 · ExternalCitation · doi-reference
Post-tuberculosis lung disease: Towards prevention, diagnosis, and care
10.1016/s2213-2600(24)00429-6 · ExternalCitation · doi-reference
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: A cluster-randomised trial
10.1016/s2214-109x(23)00430-8 · ExternalCitation · doi-reference
The impacts of donor transitions on health systems in middle-income countries: A scoping review
10.1093/heapol/czac063 · ExternalCitation · doi-reference
Patient outcomes associated with post-tuberculosis lung damage in Malawi: A prospective cohort study
10.1136/thoraxjnl-2019-213808 · ExternalCitation · doi-reference
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
10.1183/13993003.00655-2019 · ExternalCitation · doi-reference
Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: A systematic review with network meta-analyses
10.1186/s12879-017-2377-x · ExternalCitation · doi-reference
Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: A systematic review
10.1186/s12879-025-10832-7 · ExternalCitation · doi-reference
Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru
10.1186/s12889-020-10098-5 · ExternalCitation · doi-reference
Exploring providers’ perspectives of a community based TB approach in Southern Ethiopia: Implication for community based approaches
10.1186/s12913-015-1149-9 · ExternalCitation · doi-reference
The impact of loss of PEPFAR support on HIV services at health facilities in low-burden districts in Uganda
10.1186/s12913-021-06316-4 · ExternalCitation · doi-reference
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: A qualitative study of adolescents, caretakers and health workers
10.1186/s12981-024-00643-2 · ExternalCitation · doi-reference
Systematic review of the exploration, preparation, implementation, sustainment (EPIS) framework
10.1186/s13012-018-0842-6 · ExternalCitation · doi-reference
Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021
10.1186/s40249-024-01227-y · ExternalCitation · doi-reference
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial
10.1371/journal.pgph.0003347 · ExternalCitation · doi-reference
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
10.15585/mmwr.rr6901a1 · ExternalCitation · doi-reference
Perceived stigma related to TB preventive therapy
10.5588/ijtld.22.0570 · ExternalCitation · doi-reference
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
10.5588/ijtldopen.23.0283 · ExternalCitation · doi-reference
More is needed to end TB: Commentary on the United Nations High-Level Meeting on TB
10.5588/ijtldopen.23.0576 · ExternalCitation · doi-reference
Reasons for poor uptake of TB preventive therapy in South Africa
10.5588/pha.22.0030 · ExternalCitation · doi-reference
